growth factors. After culturing cells for 24 hours, CD38'" cells essentially remained a noncycling population with only 5.1% 5 3.0% of the cells cycling, whereas 44.2% & 6.940 of the CD38hi cells were in DNA synthesis. Gradually CD38'" cells were recruited into cycle, such that by 72 hours, approximately 28% of the CD38'" cells were in S-phase. However, during 6 days of culture, the percentage of cycling CD38'" cells never exceeded the prolierative response observed for CD38hi cells. Phenotype analysis conducted at day 6 indicated that 86% of the CD38h' population were no longer phenotypically CD34+/38hi, while 60% of CD38'" cells maintained a CD34+/38I0 phenotype. Long-term cultures initiated with 6-day in vitro-expanded CD38" cells showed approximately a twofold decrease in clonogenic activity attributable t o a loss of erythroid precursors and a decrease in GM colonies. Thus, a proportion of CD38'" cells capable of generating CFU was maintained even after exposure to growth factors. 0 1995 by The American Society of Hematology.
(CD71),' and less well-defined surface markers that are heterogeneously expressed (CD45RA, CD38, Thyl).'-4 Whether one combination of markers provides a clear advantage over others for isolating candidate stem cells is still debated.
In the current report, the CD34' population is divided on the basis of high and low expression of CD38. The rationale for choosing CD38 antigen expression was based on previous work indicating that lineage-negative CD38'" cells are highly enriched for blast colony-forming cells, while CD38h' cells are associated with lineage commitment and lack the ability to generate clonogenic precursors. 3 The purpose of our study was to further define functional differences that may be associated with variable CD38 expression. Toward this end, we examined the cell cycle status and clonogenic potential of enriched CD38'" and CD38h' subpopulations immediately after their isolation and after the cells had been exposed to serum-deprived medium supplemented with cytokines. The data obtained from this study indicate that the CD38'" subpopulation is functionally distinct from the CD38'" subpopulation with respect to cell cycle kinetics and cytokine responsiveness.
MATERIALS AND METHODS
Normal human bone marrow. Two sources of bone marrow were used for these studies. Normal bone marrow from transplant donors was obtained after informed consent as defined by the Internal Review Board at the Fred Hutchinson Cancer Research Center (Seattle, WA). Alternatively, normal bone marrow harvested from the vertebral bodies of organ donors was also used (Northwest Tissue Center, Seattle, WA). Bone marrow cells were layered onto ficoll (Lyrnphoprep; Nygaard, Oslo, Norway) and centrifuged, and the mononuclear cell interface was collected. The cells were subsequently washed twice with Hanks' Balanced Salt Solution (HBSS; GIBCO, Gaithersburg, MD) supplemented with 2% fetal calf serum (FCS). Contaminating erythrocytes were removed by cell lysis with 150 mmol/L NH,CI, I O mmol/L NaHCO,, 100 mmol/L EDTA. Marrow mononuclear cells from organ donor harvests were pooled, aliquoted at a concentration of 100 X lo6 cells per milliliter, and stored in IO% dimethyl sulfoxide (DMSO) at -135°C. Before staining and sorting for CD38'" and CD3Sh' cells. the frozen aliquots were thawed rapidly For personal use only. on May 29, 2017 . by guest www.bloodjournal.org From CD34'/38H' VERSUS CD34'/38L0 CELLS 1481 at 37°C. Each aliquot was slowly diluted to a final concentration of 1% DMSO using Iscove's modified Dulbecco's medium (IMDM) plus 10% FCS containing 3 U/mL of DNase I. Cells were centrifuged (2,000 rpm, 10 minutes), the supernatant was removed, and the cells were rediluted with IMDM plus 10% FCS containing 3 U/mL of DNase I. Marrow mononuclear cells harvested from transplant donors were used fresh with no prior freezing step.
Staining and sorting for CD34+/38'" and CD34+/38h' cells. To pre-enrich for CD34' cells, low-density mononuclear cells were stained with HPCA-2 for 20 minutes on ice (anti-CD34 fluorescein isothiocyanate [FITC] direct conjugate; Becton Dickinson, San Jose, CA) followed by a secondary rat-anti-mouse antibody conjugated to micromagnetic beads (Miltenyi Biotec, Sunnyvale, CA). The micromagnetic beads were incubated with the cells for 20 minutes on a rotator at 4°C. The stained cells were then applied to a MACS (Magnetic Activated Cell Sorter; Miltenyi) column for CD34+ enrichment as previously de~cribed.~ A 5-to 10-fold enrichment of CD34+ cells was obtained. The CD34"enriched fraction was stained with an antibody directed against the CD38 (20 minutes on ice) antigen (anti-CD38 R-phycoerythrin [PE] direct conjugate; Becton Dickinson, San Jose, CA). Both CD34'138'" and CD34+/38h' cells were collected using either an Epics (Coulter Electronic, Hialeah, FL) or a FACS I1 fluorescence-activated cell sorter.
Suspension cultures. Isolated CD38' O and CD38hi cells were incubated at a concentration of 50,000 cells per milliliter at 37"C, 5% COz in IMDM supplemented with 1% Nutridoma-HU (Boehringer Mannheim Biochemicals, Indianapolis, IN) with and without an added growth factor cocktail. The growth factor cocktail consisted of human recombinant interleukin-l (IL-l), IL-3, IL-6, granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage (GM) CSF, and kit ligand (KL; provided by Genetics Institute, Boston, MA), each used at a final concentration of 10 ng/mL, and erythropoietin (Amgen, Thousand Oaks, CA) at 3 U/mL. Cells were harvested at defined time intervals and analyzed for either DNA content or clonogenic activity.
Nuclear DNA staining for cell cycle analysis and cell viabilig. The nuclei of CD38'" and C D 3 P cells were stained, using a modification of the procedure described by Roberts and D ' u r s~.~ For staining, cells were centrifuged at 2,000 rpm for 5 minutes, and the culture media was removed. The cell pellet was resuspended with 125 pL of buffer A (10 m o V L Tris-HC1, pH 7.5; 20 mmoVL NaCl; and 20 mmoVL MgCI2) followed by a 5-minute incubation on ice. Buffer A containing 1% Nonidet-P40 (125 pL) was added, and the cells were vortexed and incubated for another 5 minutes on ice. RNase free from DNase (Boehringer Mannheim) was added to a final concentration of 10 pg/mL, and cells were incubated at 37°C for 30 minutes. Nuclear DNA was stained with 250 pL of propidium iodide ( l mg/mL; Sigma, St. Louis, MO) in HBSS for 20 minutes on ice. Cellular DNA content was measured by FACSCAN analysis (Becton Dickinson). Data were collected using a linear scale and stored in list mode for subsequent cell cycle analysis. The percentage of cells within each phase of the cell cycle (G&,, S, and G2/M) was calculated using the Multi-cycle software program (Phoenix Flow Software Products, San Diego, CA). Data were accepted when the pre-established cell cycle parameters for the controls, HL-60 or KGla cells, were within 1 standard deviation of the mean.
To monitor cell viability, data acquisition of propidium iodide (PI)-fluorescence was collected in a logarithmic mode and stored in list mode for subsequent analysis.' Dead cells were defined as the nuclear events with a DNA content less than 2n and viable cells as those events with a DNA content s 2 n . The percentage of viable cells was calculated by dividing the number of cycling cells with a DNA content 2 2 n by the total number of cells (dead plus viable cells) and multiplying by 100. Alternatively, cell viability was monitored after staining the cells with 7 amino-actinomycin D (7-AAD) as described under Phenotype Analysis.
Phenotype analysis. Phenotype analysis was performed on cultured cells to identify changes in CD38 and CD34 antigen expression. Cultured cells were centrifuged (2,000 rpm, 10 minutes), supernatant was removed, and the cells were incubated with mouse normal serum to block active binding sites. Cells were then restained with FITC-conjugated mouse anti-CD34 and PE-conjugated mouse anti-CD38 according to the manufacturer's instructions (Becton Dickinson). The appropriate isotype controls were used to identify background staining. After 10 minutes on ice, the cells were centrifuged (2,000 rpm, 10 minutes), supernatant was removed, and 0.5 mL phosphate-buffered saline (PBS)/l% bovine serum albumin (BSA) containing 2 pg/mL of the DNA stain 7-AAD was added to the cell pellet. Three-color analysis was accomplished using a FACStar Plus (Becton Dickinson). Before analysis, reference microbeads were used to calibrate fluorescent channels and the forward side scatter channel (Flow Cytometry Standards Corp, Research Triangle Park, NC) so that cellular phenotypes from different days could be directly compared with one another.
Short-term colony assays. The number of committed hematopoietic progenitors capable of giving rise to colonies was determined in standard cultures using 1 mL of 1.2% methylcellulose (Dow Chemical CO, Midland, MI) containing 25% FCS (Lot #796; Hyclone, Logan, UT), 2.5% BSA, 100 U/mL penicillin, 100 mg/mL streptomycin sulfate, and 120 p m o f i P-mercaptoethanol. Recombinant growth factors IL-1, IL-3, IL-6, G-CSF, GM-CSF, and KL were added at a final concentration of 10 ng/mL and erythropoietin at 3 U/mL in IMDM. Each plate was scored for erythroid, granulocyte, and multilineage colonies after culturing the cells for 14 days at 3 7 T , 5% CO*.
Stromal cultures. The ability of isolated CD38'" and CD38hi cells to generate colony-forming units (CFU) after culturing on competent stromal layer cells was determined by using a modification of previously described proced~res.'.~ Briefly, stromal layers were established in a T-25 flask and fed with IMDM supplemented with 12.5% FCS, 12.5% horse serum, 100 U/mL penicillin, 100 pg/mL streptomycin sulfate, 0.4 mg/mL of L-glutamine, 0.04 mg/mL hydrocortisone sodium succinate, and 0.8 mg/mL P-mercaptoethanol. The stromal layers were maintained at 37°C in an atmosphere of 5% COz. Once reaching confluence, the adherent layers were trypsinized, irradiated (1,500 cGy using a I3'Cs irradiator), and transferred to 24-well plates. Irradiated stromal layers were seeded in triplicate with either 3,000 CD38'" or 3,000 CD38hi hematopoietic progenitor cells immediately after their isolation or after they were exposed to IL-1, IL-3, IL-6, G-CSF, GM-CSF, or KL for 6 days. Cultures were maintained at 33°C. 5% CO2 and fed on a weekly basis by demidepletion. After 4 weeks, both the nonadherent and adherent layers were tested for CFU content. Cells from the nonadherent layer were directly plated onto two 35-mm methylcellulose plates. The cells from the adherent layers were detached using trypsin before plating them onto two 35-mm methylcellulose plates.
RESULTS

Isolation of CD34'138'" and CD34+/38h' subpopulations.
To obtain a sufficient number of CD3Sh' and CD38" cells for these studies, we used frozen aliquots of organ donor bone marrow. Starting with 1.6 X IO9 marrow-derived mononuclear cells, we obtained a 5-to IO-fold pre-enrichment of CD34+ cells, with an average total yield of 27 X IO6 cells using a MACS. The pre-enriched CD34' population was then sorted for CD38'" and CD3Shi cells (Fig 1) . An 
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CD38hi and CD38'" populations, the cells were reanalyzed to check for purity. FACSCAN analysis indicated that sorted CD3ghi and CD38'" subpopulations contained on average less than 2% contaminating CD38'" and less than 0.5% contaminating CD3gh', respectively (data not shown).
Clonogenic potential of CD38"' versus CD3d" cells. To assess the clonogenic potential of freshly isolated CD3gh' and CD38'" subpopulations, we monitored both CFU in short-term colony assays and CFU precursors in long-term cultures (LTC). In agreement with previously published data,"' consistently fewer primary colonies were generated by CD38'" than by CD3gh' cells when monitored by the shortterm colony assay. In four separate experiments performed in duplicate, 39 5 4 and 18 5 8 CFU (mean 5 SD; P < .01, Student's t-test) were obtained per 1,000 CD3ghi and CD38'" cells plated, respectively. Erythroid colony formation accounted for the major difference in clonogenic activity, with CD38hi cells generating twice as many erythroid colonies as CD38'" cells.
As the LTC assay is the best in vitro method to approximate early hematopoietic progenitor cells,x~').'' we monitored the clonogenic activities of CD3gh' and CD38'" cells after 4 weeks of culture on competent stromal layers. Consistent with previous data,"'." stromal layers seeded with CD38'" cells generated clonogenic precursors in both the nonadherent and adherent layers. In three separate experiments performed in triplicate, S1 to 330 colonies were obtained at a frequency of 52 5 1 I .7 (mean 5 SEM) colonies per 1.000 CD38'" cells plated. In two separate experiments performed in duplicate, one to six colonies were obtained at a frequency of 3 5 1.5 (mean 5 SEM) colonies per 1,000 CD38"' cells plated. Thus, as expected, the majority of progenitors capable of producing CFU in LTC were present in the CD38'" subpopulation, indicating that the more immature cells were contained within the CD38'" subpopulation.
Majority of C D 3 P cells remain quiescent @er a 24-hour cyrokine exposure. Having confirmed that CD3ghi and CD38'" subpopulations were functionally distinct with respect to their clonogenic activity, we determined the proliferative status for each subpopulation immediately after their isolation and after exposure to growth factors. To determine the cell cycle status of CD38'" and CD38hi cells, nuclei were stained with PI, and fluorescence emission was monitored using flow cytometry (Fig 2) . Cell cycle analysis before in vitro stimulation with growth factors indicated that 96% 2 4% of the CD38'" and 86% 5 2% of CD3Sh' cells (mean 5 SD; P = .02, Students r test) were within the GJG, compartment of the cell cycle (Table l ) , indicating that substantially fewer CD38'" cells relative to CD38h' cells were in the Sphase of the cell cycle immediately after their isolation. Similar results were obtained from fresh bone marrow samples harvested from transplant donors that had not undergone a freeze-thaw protocol.
To monitor the proliferative response of the subpopulations after exposure to cytokines, the cells were placed in serum-deprived suspension cultures with a growth factor cocktail containing IL-l, IL-3, IL-6, G-CSF, GM-CSF, KL, and erythropoietin and incubated for 24 hours. This growth factor combination was chosen to obtain a maximum proliferative response in serum-deprived medium. Cell cycle analysis indicated that CD38'" cells were essentially nonresponsive, with approximately 5% of the cells in S-phase after a . , . (Table l) . Similar results were obtained for CD38'" cells when each growth factor was added alone, or when the growth factor combinations of IL-3 plus KL or IL-3 plus IL-6 were used (data not shown). In contrast, the percentage of CD3Sh' cells in S-phase increased approximately 3.5-fold after 24 hours of incubation with the growth factor cocktail (Table 1 ). In addition, the growth factor combination of IL-3 plus KL stimulated CD3ghi cells to proliferate to the same extent as the growth factor cocktail (data not shown). Even when added as individual growth factors, ILl , IL-3, IL-6, and KL stimulated CD3Shi cells to proliferate above background levels but below the cycling levels observed with the growth factor cocktail. Together, these results indicate that CD38hi cells were highly responsive to proliferative signals, unlike the CD38'" cells, which remained CD38'" cells show a delayed proliferative response to growthfacror inducrion. To investigate the kinetics of proliferation for the CD38'" and CD3gh' subpopulations, their cell cycle status was monitored over an extended period with and without the addition of growth factors. To insure that cell viability was maintained during the course of the 6-day cell cycle analysis, both cell death and cell cycle status were monitored simultaneously.' In the presence of recombinant cytokines, greater than 90% cell viability was maintained over the 6 days of analysis (Fig 3) . whereas in the absence of cytokines 12% 2 5% of CD3ghi and 8% 2 3% of CD38'" cells were dead within 24 hours. At 6 days of culture, greater than 50% of the and CD38'" cells were nonviable in the serum-deprived medium not supplemented with the growth factor cocktail (Fig 3) . Thus, both CD38h' and CD38'" cells required the addition of the growth factor cocktail to remain viable.
After cytokine exposure the number of cycling CD38'" cells gradually increased and then plateaued (Fig 4A) . The maximum proliferative response of CD38'" cells was attained after 3 days, at which time approximately 28% of the CD38'" cells were in the S/G2M phase of the cell cycle. In contrast, cells underwent an initial proliferative burst, and then approximately 40% of the CD3gh' cells continued to cycle throughout the 6-day time period. Interestingly, the percent of cycling CD38'" cells never exceeded the proliferative response observed for CD38hi cells (Fig 4A) .
To determine whether added cytokines were responsible for the CD38h' and CD38'" proliferative responses, the cell (11-1. IL-3,11-6 cycle status of each population was monitored in the absence of added growth factors. Even though cell viability decreased with time in the absence of added growth factors, the cell cycle status of the viable cells was determined. Of the viable cells, approximately 3% of CD38" and approximately 20% of CD38h' cells continued to proliferate despite a decrease in cell viability (Fig 4B) . Hence, the proliferative response observed in the presence of added cytokines was attributable to added growth factors and not to unknown factors present in the serum-deprived medium.
The phenotype of the CD38hi and CD38'" cells was monitored during the 6-day culture period. Figure 5 represents the data obtained from a single experiment, but similar results were also obtained from two additional experiments. First, immediately after the isolation of the CD38"' and CD38'" cells, the populations were analyzed for their purity (Fig 5A and D) . In this particular experiment, only 1% of the CD38hi and only 2% of the CD38'" cells did not fall within the original sort windows. However, after in vitro culture for 24 hours, approximately 19% of CD38h' and approximately 12% of CD38'" cells fell outside of the original sort windows (Fig 5B and E) . After 6 days of culture, approximately 86% of the viable cells from the CD38" population were no longer confined to the region defined by the original CD38h' sort window (Fig 5C) . The phenotype changes observed for CD38hi cells after culture were due primarily to an apparent loss in CD34 as well as CD38 antigen expression. In contrast, approximately 60% of the viable cells from the CD38" population not only remained phenotypically CD38'", but also CD34'. Phenotype changes observed with the CD38" population were primarily due to cells that had lost their CD34 antigen expression. However, a small proportion of CD38'" cells maintained their CD34 antigen expression and also stained brighter for CD38.
CD38'" cells retain LTC clonogenic activity afrer in vitro expansion. To determine whether the CD38" proliferative response associated with cytokine exposure reflected an expansion of cells with long-term repopulating ability, CD38'" cells exposed to growth factor cocktail for 6 days in serum-deprived liquid suspension cultures were plated onto LTC stromal layers. After 4 weeks of culture on stroma, both the nonadherent and adherent cells were assessed for colony formation. As previously discussed, CD38'" cells without prior cytokine exposure generated 52 2 11.7 (mean 2 SEM) colonies per 1,000 cells plated. However, CD38"' cells preincubated with cytokines for 6 days before plating onto LTC produced only 15 2 2.9 (mean ? SEM) colonies per 1,000 cells plated. This represents a 70% decrease in clonogenic precursors in the CD38'" cells incubated with cytokines before LTC. An examination of colony morphology showed that before cytokine exposure, approximately 3.3% t 1.4% (mean 2 SD) of CFU generated from CD38'" cells in LTC gave rise to erythroid bursts. After 6 days of For personal use only. on May 29, 2017 . by guest www.bloodjournal.org From 
cytokine exposure, the CD38'" cells did not generate any CFU in LTC with erythroid potential.
DISCUSSION
In this study, we show that bone marrow CD34' cells can be sorted into a highly proliferative and a noncycling CD38'" populations that differ in their primary clonogenic activity, in their ability to generate CFU in LTC, and in their response to cytokines. After a 24-hour cytokine exposure to a serum-free growth factor cocktail, the CD3Shi cells underwent a dramatic proliferative burst. The pronounced proliferative response of the CD3ghi subpopulation to growth factors indicates that the majority of these cells are developmentally primed to receive proliferative signals and initiate DNA synthesis. In fact, some CD3gh' cells proliferated without extrinsically added signals (Fig 4B) . After 6 days of cytokine exposure, the majority of the CD38hi cells no longer expressed either CD34 or CD38 antigen, suggesting that these cells had differentiated. Further, the clonogenic potential of CD38hi cells in primary cultures was significantly greater than that of CD38'" cells. This is consistent with previously published data showing that CD34', CD45RA'", CD7 1 hi and CD34', HLA-DR'" cells are more clonogenic in primary colony assays than are CD34', CD4SRA'", CD71'" or CD34', HLA-DR-cells, respectively.'.'
In contrast to observations made with CD3Rhi cells, the CD38'" cells were relatively unresponsive to cytokines (Table l). This is also consistent with previously published data showing that CD34', HLA-DR-cells" and CD34', CD4SRA'". CD71'" cells'3 do not rapidly enter the S-phase of the cell cycle. In addition to demonstrating that the CD38'" proliferative response is delayed, our data also indicate that the response that is detected is limited to a small proportion of cells. We speculate that this represents heterogeneity In keeping with this, we noted that a comparable proportion of cells became CD38'" after cytokine exposure (Fig SF) . An alternative explanation would be that contaminating CD3gh' cells are responsible for both these observations. This is unlikely, however. as the CD38'" contamination of the sorted population was less than 0.5%.
The more important observation is that approximately 60% of stimulated CD38'" cells remain both CD34.' and CD38'" after 6 days of culture. However. it is not clear at this time whether any of the cells with the persistent CD34'/ CD38'" phenotype actually proliferated. or whether all the cell cycle activity could be attributed to those CD38'" cells that subsequently became CD3gh'.
Currently, considerable effort is focused on defining in vitro growth factor conditions that stimulate the proliferation of pluripotential stem cells without inducing differentiation. Such studies measure persistence or expansion of clonogenic precursors maintained in LTC or as primary CFU after various incubation strategies.'"23 Among the extracellular signals controlling hematopoiesis that have been studied are a wide range of cytokines and adhesion molecules that act through receptor-mediated pathways to exert their effects on both early and late progenitors. Recent data indicate that combinations of cytokines, such as IL-3 with synergistic growth factors IL-6 or KL, stimulate colony formation from CD34'/HLA-DR-hematopoietic progenitors,' and IL-I plus KL stimulates the recovery of peripheral blood cells in lethally irradiated mice.'4 Furthermore, Koller et al' 5 have also demonstrated that by using a continuous perfusion system. clonogenic precursors as measured in LTC are expanded.
In the current study, the potential of the isolated CD38'" cells to produce CFU after 4 weeks on LTC was determined For personal use only. on May 29, 2017 . by guest www.bloodjournal.org From before and after incubation with cytokines. After 6 days of cytokine exposure, approximately one fourth of the CD38'" cells entered S-phase. This, however, was not associated with an increase in LTC clonogenic activity. Instead, there was approximately a 60% loss in clonogenic activity attributable to a complete absence of erythroid bursts, as well as a decrease in GM colonies. These data can be interpreted to indicate that the growth factor cocktail, which included erythropoietin, preferentially induced immature erythroid precursors to divide and differentiate to the extent that they could not be maintained on LTC for 4 weeks.
In conclusion, our data show that human bone marrow CD38h' and CD38'" subpopulations are functionally distinct based on important differences in cell cycle kinetics and cytokine responsiveness. Recently, Fleming et a]*' showed that murine Rl1-123~' and Rh-123'" hematopoietic stem cells can be divided into resting and actively proliferative cells, respectively. Given that hematopoietic cells responsible for rapid engraftment consist of cells that are highly proliferative and short-lived, while cells capable of long-term engraftment comprise primarily a noncycling p o p~l a t i o n ,~~~*~ it is reasonable to speculate that the CD38h' and CD38'" subpopulations may represent compartments of human hematopoietic cells responsible for rapid and long-term bone marrow engraftment, respectively.
